![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ESYT1 mRNA] | CTD | PMID:31150632 | 1,2-dichloroethane | increases expression | ISO | RGD:736516 | 6480464 | ethylene dichloride results in increased expression of ESYT1 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | increases expression | ISO | RGD:736516 | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of ESYT1 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:736516 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ESYT1 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ESYT1 mRNA | CTD | PMID:34747641 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 6-dinitrotoluene affects the expression of ESYT1 mRNA | CTD | PMID:21346803 | 2-amino-14,16-dimethyloctadecan-3-ol | decreases expression | ISO | RGD:733690 | 6480464 | 2-amino-14, 16-dimethyloctadecan-3-ol results in decreased expression of ESYT1 protein | CTD | PMID:32044396 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:736516 | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ESYT1 mRNA | CTD | PMID:20188158 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:733690 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ESYT1 mRNA | CTD | PMID:28628672 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:736516 | 6480464 | Fenretinide results in decreased expression of ESYT1 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of ESYT1 mRNA | CTD | PMID:24780913 | aflatoxin B1 | increases methylation | ISO | RGD:733690 | 6480464 | Aflatoxin B1 results in increased methylation of ESYT1 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | RGD:733690 | 6480464 | Tretinoin results in decreased expression of ESYT1 mRNA | CTD | PMID:33167477 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ESYT1 mRNA | CTD | PMID:16483693 | aristolochic acid A | decreases expression | ISO | RGD:733690 | 6480464 | aristolochic acid I results in decreased expression of ESYT1 mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | RGD:733690 | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to ESYT1 mRNA] | CTD | PMID:32406909 | arsenous acid | increases expression | ISO | RGD:733690 | 6480464 | Arsenic Trioxide results in increased expression of ESYT1 protein | CTD | PMID:25419056 | benzo[a]pyrene | increases expression | ISO | RGD:736516 | 6480464 | Benzo(a)pyrene results in increased expression of ESYT1 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | affects methylation | ISO | RGD:733690 | 6480464 | Benzo(a)pyrene affects the methylation of ESYT1 intron | CTD | PMID:30157460 | benzo[a]pyrene | increases methylation | ISO | RGD:736516 | 6480464 | Benzo(a)pyrene results in increased methylation of ESYT1 promoter | CTD | PMID:27901495 | benzo[e]pyrene | increases methylation | ISO | RGD:733690 | 6480464 | benzo(e)pyrene results in increased methylation of ESYT1 intron | CTD | PMID:30157460 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ESYT1 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ESYT1 mRNA | CTD | PMID:30816183 more ... | bisphenol A | multiple interactions | ISO | RGD:733690 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ESYT1 mRNA | CTD | PMID:28628672 | Bisphenol B | increases expression | ISO | RGD:733690 | 6480464 | bisphenol B results in increased expression of ESYT1 protein | CTD | PMID:34186270 | caffeine | increases phosphorylation | ISO | RGD:733690 | 6480464 | Caffeine results in increased phosphorylation of ESYT1 protein | CTD | PMID:35688186 | carbamazepine | affects expression | ISO | RGD:733690 | 6480464 | Carbamazepine affects the expression of ESYT1 mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | ISO | RGD:736516 | 6480464 | Nanotubes, Carbon analog results in increased expression of ESYT1 mRNA | CTD | PMID:25554681, PMID:25620056 | CGP 52608 | multiple interactions | ISO | RGD:733690 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ESYT1 gene] | CTD | PMID:28238834 | chlordecone | increases expression | ISO | RGD:736516 | 6480464 | Chlordecone results in increased expression of ESYT1 mRNA | CTD | PMID:33711761 | choline | multiple interactions | ISO | RGD:736516 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ESYT1 gene | CTD | PMID:20938992 | cobalt dichloride | decreases expression | ISO | RGD:733690 | 6480464 | cobaltous chloride results in decreased expression of ESYT1 mRNA | CTD | PMID:19320972 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of ESYT1 mRNA | CTD | PMID:26577399 | cyclosporin A | increases expression | ISO | RGD:733690 | 6480464 | Cyclosporine results in increased expression of ESYT1 mRNA | CTD | PMID:25562108 | decabromodiphenyl ether | decreases expression | EXP | | 6480464 | decabromobiphenyl ether results in decreased expression of ESYT1 mRNA | CTD | PMID:23640034 | dexamethasone | multiple interactions | ISO | RGD:733690 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ESYT1 mRNA | CTD | PMID:28628672 | diarsenic trioxide | increases expression | ISO | RGD:733690 | 6480464 | Arsenic Trioxide results in increased expression of ESYT1 protein | CTD | PMID:25419056 | diazinon | increases methylation | ISO | RGD:733690 | 6480464 | Diazinon results in increased methylation of ESYT1 gene | CTD | PMID:22964155 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of ESYT1 mRNA | CTD | PMID:21266533 | dieldrin | decreases expression | ISO | RGD:733690 | 6480464 | Dieldrin results in decreased expression of ESYT1 mRNA | CTD | PMID:31068361 | diuron | decreases expression | ISO | RGD:733690 | 6480464 | Diuron results in decreased expression of ESYT1 mRNA | CTD | PMID:35967413 | doxorubicin | increases expression | ISO | RGD:733690 | 6480464 | Doxorubicin results in increased expression of ESYT1 mRNA | CTD | PMID:29803840 | enzyme inhibitor | multiple interactions | ISO | RGD:733690 | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ESYT1 protein | CTD | PMID:23301498 | epoxiconazole | decreases expression | ISO | RGD:736516 | 6480464 | epoxiconazole results in decreased expression of ESYT1 mRNA | CTD | PMID:35436446 | fenthion | decreases expression | ISO | RGD:736516 | 6480464 | Fenthion results in decreased expression of ESYT1 mRNA | CTD | PMID:34813904 | folic acid | multiple interactions | ISO | RGD:736516 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ESYT1 gene | CTD | PMID:20938992 | indometacin | multiple interactions | ISO | RGD:733690 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ESYT1 mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | RGD:733690 | 6480464 | Ivermectin results in decreased expression of ESYT1 protein | CTD | PMID:32959892 | L-methionine | multiple interactions | ISO | RGD:736516 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ESYT1 gene | CTD | PMID:20938992 | lead(0) | affects expression | ISO | RGD:733690 | 6480464 | Lead affects the expression of ESYT1 mRNA | CTD | PMID:28903495 | methapyrilene | increases methylation | ISO | RGD:733690 | 6480464 | Methapyrilene results in increased methylation of ESYT1 intron | CTD | PMID:30157460 | methotrexate | affects response to substance | ISO | RGD:733690 | 6480464 | ESYT1 protein affects the susceptibility to Methotrexate | CTD | PMID:16217747 | nickel atom | decreases expression | ISO | RGD:733690 | 6480464 | Nickel results in decreased expression of ESYT1 mRNA | CTD | PMID:23195993 | paracetamol | affects expression | ISO | RGD:736516 | 6480464 | Acetaminophen affects the expression of ESYT1 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | RGD:733690 | 6480464 | Acetaminophen results in increased expression of ESYT1 mRNA | CTD | PMID:22230336, PMID:29067470 | S-butyl-DL-homocysteine (S,R)-sulfoximine | decreases expression | ISO | RGD:736516 | 6480464 | Buthionine Sulfoximine results in decreased expression of ESYT1 mRNA | CTD | PMID:15878706 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of ESYT1 protein | CTD | PMID:29459688 | sodium arsenite | increases expression | ISO | RGD:736516 | 6480464 | sodium arsenite results in increased expression of ESYT1 mRNA | CTD | PMID:36209798 | sodium fluoride | decreases expression | ISO | RGD:736516 | 6480464 | Sodium Fluoride results in decreased expression of ESYT1 protein | CTD | PMID:27548804, PMID:28918527 | testosterone | decreases expression | ISO | RGD:733690 | 6480464 | Testosterone results in decreased expression of ESYT1 mRNA | CTD | PMID:33359661 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of ESYT1 mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ESYT1 mRNA] | CTD | PMID:31150632 | thapsigargin | increases expression | EXP | | 6480464 | Thapsigargin results in increased expression of ESYT1 protein | CTD | PMID:35544339 | trovafloxacin | decreases expression | ISO | RGD:736516 | 6480464 | trovafloxacin results in decreased expression of ESYT1 mRNA | CTD | PMID:35537566 | valproic acid | increases expression | ISO | RGD:736516 | 6480464 | Valproic Acid results in increased expression of ESYT1 mRNA | CTD | PMID:21427059 | valproic acid | affects expression | ISO | RGD:733690 | 6480464 | Valproic Acid affects the expression of ESYT1 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | RGD:733690 | 6480464 | Valproic Acid results in decreased expression of ESYT1 mRNA | CTD | PMID:29154799 | vancomycin | decreases expression | ISO | RGD:736516 | 6480464 | Vancomycin results in decreased expression of ESYT1 mRNA | CTD | PMID:18930951 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of ESYT1 mRNA | CTD | PMID:23034163 | |